Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Valion Bio (TIVC) Gains from Investment Securities (2021 - 2025)

Valion Bio has reported Gains from Investment Securities over the past 5 years, most recently at $101105.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 1720.07% year-over-year to $101105.0; the TTM value through Dec 2025 reached $101105.0, up 1720.07%, while the annual FY2025 figure was $101105.0, 1720.07% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was $101105.0 at Valion Bio, down from $355368.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $749261.0 in Q1 2022 and troughed at $188.0 in Q4 2022.
  • A 5-year average of $217802.8 and a median of $45000.0 in 2023 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 99.93% in 2022 and later soared 2966.67% in 2023.
  • Year by year, Gains from Investment Securities stood at $280250.0 in 2021, then plummeted by 99.93% to $188.0 in 2022, then skyrocketed by 125.53% to $424.0 in 2023, then skyrocketed by 1210.14% to $5555.0 in 2024, then surged by 1720.07% to $101105.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for TIVC at $101105.0 in Q4 2025, $355368.0 in Q3 2025, and $4000.0 in Q2 2025.